WANG-DA LIULin, Meng-ShuanMeng-ShuanLinShih, Ming-ChiehMing-ChiehShihHSIN-YUN SUNLi, Guei-ChiGuei-ChiLiYU-SHAN HUANGYU-CHUNG CHUANGKUAN-YIN LINWu, Pei-YingPei-YingWuChen, Ling-YaLing-YaChenLiu, Wen-ChunWen-ChunLiuSu, Yi-ChingYi-ChingSuHe, Pu-ChiPu-ChiHeChen, Yi-TingYi-TingChenLin, Chia-YiChia-YiLinCheng, Yu-ChenYu-ChenChengYao, YiYiYaoYeh, Yi-ChenYi-ChenYehLiu, Chia-ChiChia-ChiLiuPan, Mei-YanMei-YanPanLuo, Yu-ZhenYu-ZhenLuoChang, Hsi-YenHsi-YenChangJANN-TAY WANGWANG-HUEI SHENGSZU-MIN HSIEHSUI-YUAN CHANGCHIEN-CHING HUNG2024-03-252024-03-252024-02-2616841182https://scholars.lib.ntu.edu.tw/handle/123456789/641284Real-world vaccine effectiveness following the third dose of vaccination against SARS-CoV-2 remains less investigated among people with HIV (PWH).enBNT162b2 vaccine; Booster vaccination; Humoral immunity; Immunogenicity; Serologic response; mRNA-1273 vaccine[SDGs]SDG3Effectiveness and evolution of anti-SARS-CoV-2 spike protein titers after three doses of COVID-19 vaccination in people with HIVjournal article10.1016/j.jmii.2024.02.004384292062-s2.0-85186348182https://api.elsevier.com/content/abstract/scopus_id/85186348182